Advanced search
Publication Cover
Epigenomics Volume 8, 2016 - Issue 1
Submit an article Journal homepage
107
Views
0
CrossRef citations to date
0
Altmetric
Commentary

The Failure of Epigenetic Combination Therapy for Cancer and what it Might be Telling us about DNA Methylation Inhibitors

Allen S Yang1 Spectrum Pharmaceuticals, 157 Technology Drive, Irvine, CA92618, USACorrespondence[email protected]
View further author information
&
Brandon J Yang2 Albert Einstein Academy, 28141 Kelly Johnson Parkway, Santa Clarita, CA91355, USAView further author information
Pages 9-12 | Received 04 Sep 2015, Accepted 18 Sep 2015, Published online: 23 Dec 2015

References

  • Jones PA , BaylinSB . The epigenomics of cancer . Cell128 ( 4 ), 683 – 692 ( 2007 ).
  • Fenaux P , MuftiGJ , Hellstrom-LindbergEet al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, Phase III study . Lancet Oncol.10 ( 3 ), 223 – 232 ( 2009 ).
  • Farydak® (Panobinostat), prescribing information . Novartis Pharmaceuticals Corporation , NJ, USA ( 2015 ).
  • Sekeres MA , OthusM , ListAFet al. A randomized Phase II study of Azacitidine combined with Lenalidomide or with Vorinostat vs Azacitidine monotherapy in higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic . Blood124 ( 21 ), LBA-5 ( 2014 ).
  • Prebet T , SunZ , FigueroaMEet al. Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905 . J. Clin. Oncol.32 ( 12 ), 1242 – 1248 ( 2014 ).
  • Issa JP , Garcia-ManeroG , HuangXet al. Results of Phase 2 randomized study of low-dose decitabine with or without valproic acid in patients with myelodysplastic syndrome and acute myelogenous leukemia . Cancer121 ( 4 ), 556 – 561 ( 2015 ).
  • Vidaza® (Azacitidine for injection), prescribing information . Celgene Corporation Summit , NJ, USA ( 2014 ).
  • Dacogen® (Decitabine), prescribing information . Otsuka America Pharmaceutical, Inc. , MD, USA ( 2014 ).
  • Yang AS , DoshiKD , ChoiSWet al. DNA methylation changes after 5-aza-2’-deoxycytidine therapy in patients with leukemia . Cancer Res.66 ( 10 ), 5495 – 5503 ( 2006 ).
  • Shen L , KantarjianH , GuoYet al. DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes . J. Clin. Oncol.28 ( 4 ), 605 – 613 ( 2010 ).
  • Zolinza® (Vorinostat), prescribing information . Merck & Co, Inc. , NJ, USA ( 2013 ).
  • Beleodaq® (Belinostat), prescribing information . Spectrum Pharmaceuticals, CA, USA ( 2014 ).
  • Istodax® (Romidepsin), perscribing information . Celgene Corporation Summit, NJ, USA ( 2013 )
  • Griffiths EA , GoreSD . DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes . Semin. Hematol.45 ( 1 ), 23 – 30 ( 2008 ).
  • Ornstein MC , MukherjeeS , SekeresMA . More is better: combination therapies for myelodysplastic syndromes . Best Pract. Res. Clin. Haematol.28 ( 1 ), 22 – 31 ( 2015 ).
  • Bose P , DaiY , GrantS . Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights . Pharmacol. Ther.143 ( 3 ), 323 – 336 ( 2014 ).
  • Grishina O , SchmoorC , DohnerKet al. DECIDER: prospective randomized multicenter Phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy . BMC Cancer15 , 430 ( 2015 ).
  • Mei Pharma I . MEI pharma announces top-line data from randomized Phase II clinical study of practinostat in front-line myelodysplastic syndrome ( 2015 ). http://investor.meipharma.com/2015-03-23-MEI-Pharma-Announces-Top-Line-Data-From-Randomized-Phase-II-Clinical-Study-Of-Pracinostat-In-Front-Line-Myelodysplastic-Syndrome
  • Voso MT , SantiniV , FabianiEet al. Why methylation is not a marker predictive of response to hypomethylating agents . Haematologica99 ( 4 ), 613 – 619 ( 2014 ).
  • Ley TJ , DingL , WalterMJet al. DNMT3A mutations in acute myeloid leukemia . N. Engl. J. Med.363 ( 25 ), 2424 – 2433 ( 2010 ).
  • Metzeler KH , WalkerA , GeyerSet al. DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia . Leukemia26 ( 5 ), 1106 – 1107 ( 2012 ).
  • Traina F , VisconteV , ElsonPet al. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms . Leukemia28 ( 1 ), 78 – 87 ( 2014 ).
  • Im AP , SehgalAR , CarrollMPet al. DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies . Leukemia28 ( 9 ), 1774 – 1783 ( 2014 ).
  • Dinardo CD , PatelKP , Garcia-ManeroGet al. Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents . Leukemia Lymphoma55 ( 8 ), 1925 – 1929 ( 2014 ).
  • Cowan LA , TalwarS , YangAS . Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors . Epigenomics2 ( 1 ), 71 – 86 ( 2010 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.